Ayolola Eni-Olotu
Biographic Data
| ID | 9799534 |
|---|---|
| NAME | Ayolola Eni-Olotu |
| GIVEN NAMES | Ayolola |
| FAMILY NAME | Eni-Olotu |
| SIGNATURE | ENI-OLOTU A |
| AFFILIATIONS | Imperial College London |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Who funded the research behind the Oxford–AstraZeneca Covid-19 vaccine
OBJECTIVES: The Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19, Vaxzevira or Covishield) builds on two decades of research and development (R&D) into chimpanzee adenovirus-vectored vaccine (ChAdOx) technology at the University of Oxford. This study aimed to approximate the funding for the R&D of ChAdOx and the Oxford-AstraZeneca vaccine and to assess the transparency of funding reporting mechanisms. METHODS: We conducted a scoping review an…
No prominent works on this page.
Who funded the research behind the Oxford–AstraZeneca Covid-19 vaccine
OBJECTIVES: The Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19, Vaxzevira or Covishield) builds on two decades of research and development (R&D) into chimpanzee adenovirus-vectored vaccine (ChAdOx) technology at the University of Oxford. This study aimed to approximate the funding for the R&D of ChAdOx and the Oxford-AstraZeneca vaccine and to assess the transparency of funding reporting mechanisms. METHODS: We conducted a scoping review an…
2019-20 coronavirus outbreak (1 work) · Disease (1 work) · Immune responses and vaccinations (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Political science (1 work) · SARS-CoV-2 and COVID-19 Research (1 work) · Virology (1 work) · Virus-based gene therapy research (1 work)